Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection.
NF-kappaB transcription factor is a critical regulator of the expression of genes involved in tumor formation and progression. Successful RNA interference (RNAi) therapeutics targeting NF-kappaB is challenged by small interfering RNA (siRNA) delivery systems, which can render targeted in vivo delivery, efficient endolysosomal escape, and dynamic control over activation of RNAi. Here, we report near-IR (NIR) light-inducible NF-kappaB downregulation through folate receptor-targeted hollow gold nanospheres carrying siRNA recognizing NF-kappaB p65 subunit. Using micro-positron emission tomography/computed tomography imaging, the targeted nanoconstructs exhibited significantly higher tumor uptake in nude mice bearing HeLa cervical cancer xenografts than nontargeted nanoparticles following i.v. administration. Mediated by hollow gold nanospheres, controllable cytoplasmic delivery of siRNA was obtained on NIR light irradiation through photothermal effect. Efficient downregulation of NF-kappaB p65 was achieved only in tumors irradiated with NIR light but not in nonirradiated tumors grown in the same mice. Liver, spleen, kidney, and lung were not affected by the treatments, in spite of significant uptake of the siRNA nanoparticles in these organs. We term this mode of action "photothermal transfection." Combined treatments with p65 siRNA photothermal transfection and irinotecan caused substantially enhanced tumor apoptosis and significant tumor growth delay compared with other treatment regimens. Therefore, photothermal transfection of NF-kappaB p65 siRNA could effectively sensitize the tumor to chemotherapeutic agents. Because NIR light can penetrate the skin and be delivered with high spatiotemporal control, therapeutic RNAi may benefit from this novel transfection strategy while avoiding unwanted side effect.
Lu
Wei
W
Department of Experimental Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Zhang
Guodong
G
Zhang
Rui
R
Flores
Leo G
LG
Huang
Qian
Q
Gelovani
Juri G
JG
Li
Chun
C
D000818:Animals; D003593:Cytoplasm / Q000378:metabolism; D020868:Gene Silencing; D006046:Gold / Q000737:chemistry*; D006367:HeLa Cells; D006801:Humans; D008027:Light; D008247:Lysosomes / Q000378:metabolism; D053768:Metal Nanoparticles / Q000737:chemistry*; D051379:Mice; D008819:Mice, Nude; D054118:Nanospheres / Q000737:chemistry*; D009368:Neoplasm Transplantation; D034741:RNA, Small Interfering / Q000378:metabolism; D051996:Transcription Factor RelA / Q000737:chemistry* / Q000235:genetics*
D034741:RNA, Small Interfering; D051996:Transcription Factor RelA; D006046:Gold
Angew Chem Int Ed Engl. 2005 Feb 18;44(9):1328-32
15643658
Biochim Biophys Acta. 2006 Mar;1758(3):394-403
16497269
Nat Rev Cancer. 2002 Apr;2(4):301-10
12001991
J Cell Sci. 1993 Sep;106 ( Pt 1):423-30
8270640
ACS Nano. 2009 Jan 27;3(1):80-6
19206252
Biomaterials. 2009 Apr;30(10):1928-36
19131103
Chem Commun (Camb). 2005 May 7;(17):2247-9
15856111
J Phys Chem B. 2006 Oct 12;110(40):19935-44
17020380
Oligonucleotides. 2008 Jun;18(2):123-32
18637730
Nanomedicine (Lond). 2007 Oct;2(5):681-93
17976030
Nature. 2001 May 24;411(6836):494-8
11373684
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9138-43
12886020
Nat Biotechnol. 2001 Apr;19(4):316-7
11283581
Clin Cancer Res. 2009 Feb 1;15(3):876-86
19188158
Gene Ther. 2005 Dec;12(24):1734-51
16079885
Clin Cancer Res. 2004 May 15;10(10):3333-41
15161687
ACS Nano. 2009 Jul 28;3(7):2007-15
19527019
Mol Cancer Ther. 2008 Jun;7(6):1730-9
18566244
J Am Chem Soc. 2006 Mar 22;128(11):3709-15
16536544
Annu Rev Immunol. 1998;16:225-60
9597130
Biochim Biophys Acta. 2007 May;1768(5):1211-7
17343820
J Immunol. 2006 Aug 1;177(3):1975-80
16849511
J Phys Chem C Nanomater Interfaces. 2007 Apr 6;111(17):6245-6251
20165552
Small. 2005 Mar;1(3):325-7
17193451
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54
17875985
Nanotechnology. 2008 Jan 9;19(1):015701
21730542
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13549-54
14597719
Nano Lett. 2006 Apr;6(4):662-8
16608261